Bulgaria’s Sopharma Trading 9-mo pretax profit jumps 20%

Sales revenue went up by 12% in annual terms, reaching 790.2 million levs in the January-September period, Sopharma Trading said in a stock exchange filing.

In September alone, the company’s pre-tax profit came in at 2.68 million levs as revenue climbed to 86.1 million levs from 85.3 million levs a year earlier.

Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:SFA], which held a stake of 83.24% in the company at the end of June.

As at 1512 CEST on Friday, Sopharma Trading's shares traded 0.36% higher at 5.54 levs on the Sofia bourse.

(1 euro = 1.95583 levs)